Wolverine Asset Management LLC Novavax Inc Call Options Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$8.86 - $25.04 $50,502 - $142,728
5,700 Added 36.31%
21,400 $219,000
Q2 2022

Aug 03, 2022
BUY
$36.28 - $75.29 $362,800 - $752,900
10,000 Added 175.44%
15,700 $807,000
Q1 2022

May 04, 2022
BUY
$69.73 - $142.9 $390,488 - $800,240
5,600 Added 5600.0%
5,700 $419,000
Q1 2021

May 13, 2021
BUY
$112.98 - $319.93 $11,298 - $31,993
100 New
100 $18,000

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email